Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

A Phase 3 study to assess efficacy, safety and tolerability of remibrutinib in adult and adolescent patients with moderate to severe hidrade… Ended

2024-513282-39-00 Hidradenitis Suppurativa (HS) 5 2025-05-28
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Primary Sjögren’s Disease 5 2025-04-15
"A study to test how well BI 3000202 is tolerated by people with type 1 interferonopathies" Ended

2024-514942-35-00 Type 1 interferonopathies 3 2025-04-11
Study to evaluate the safety and efficacy of a treatment consisting of immunotherapy by subcutaneous injection of a combination of Der p 1/D… Ended

2024-518519-20-01 moderate/severe allergic rhinitis/rhinoconjunctivitis w 4 2025-04-10
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-naïve Participants with Active Psoriatic Arthritis Ended

2023-509239-19-00 Active Psoriatic Arthritis 5 2025-04-03
A study to assess efficacy and safety of efgartigimod PH20 SC in adults with ocular myasthenia gravis Ended

2024-514133-38-00 Ocular Myasthenia Gravis 5 2025-03-19
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants from Jasper-Sponsor… Ended

2024-517830-17-00 Chronic Urticaria 4 2025-03-14
CHAPTER-3 – A randomised clinical trial to assess efficacy and safety of deucrictibant treatment in prophylaxis against HAE attacks in adult… Ended

2024-516247-62-00 Hereditary Angioedema 5 2025-03-10
A study to investigate improvement in pruritus of Lichen Simplex Chronicus with dupilumab injections compared with placebo in male and fema… Ended

2024-514762-39-00 Neurodermatitis 5 2025-03-03
Long Acting Cabotegravir plus Rilpivirine in People Living with HIV-1 (PLHIV) Aged ≥ 60 Years for 96 weeks. Ended

2022-502882-53-00 HIV-1 6 2025-03-03
Efficacy of doravirine + dolutegravir dual therapy in the context of antiretroviral therapy switch Ended

2023-509751-14-03 HIV 4 2025-02-27
A study to test an oral medicine, belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagn… Ended

2023-505394-32-00 chronic graft versus host disease 5 2025-02-06
A clinical trial to learn about the effects of YTB323 in people with difficult-to-treat severe inflammatory myopathies (IIM) Ended

2024-514137-38-00 Severe refractory idiopathic inflammatory myopathies (I 4 2025-02-04
A Study to Investigate the Efficacy and Safety of Solrikitug in Adults with Eosinophilic Esophagitis Ended

2024-510849-34-00 Eosinophilic Esophagitis 4 2025-02-04
Crohn's Disease: Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn’s Disease Ended

2024-516023-13-00 Crohn's disease 5 2025-01-23
Impact of Doravirine in Liver Steatosis and Fibrosis in PLWH. A pilot, proof of concept study (DORALI Study) Ended

2023-504952-87-00 Human Immunodeficiency Virus 6 2025-01-13
A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab … Ended

2024-511933-36-00 Diffuse cutaneous systemic sclerosis (dcSSc) 4 2025-01-02
Effects of IL-23 inhibition in patients with very early axial spondyloarthritis – evidence for a true disease modification? Ended

2023-507718-28-00 AXIAL SPONDYLOARTHRITIS 4 2024-12-19
A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended

2024-511738-11-00 Psoriatic arthritis 5 2024-12-18
Selective Treatment of Oral Povorcitinib in Prurigo Nodularis Study 2 (STOP-PN2) Ended

2024-511881-35-00 Prurigo Nodularis 5 2024-12-17
A trial to test the effect of leniolisib in children from 1 to 6 years of age with APDS Ended

2022-502180-38-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 5 2024-12-16
Hidradenitis Suppurativa: Evaluation of lutikizumab in Adult and Adolescent Subjects Ended

2024-510730-40-00 Hidradenitis Suppurativa 5 2024-12-12
A trial to learn how safe AZD7798 is and how well it works in adults with ileal Crohn’s disease who have an ileostomy Ended

2024-514407-33-00 Crohn’s Disease and an Ileostomy 4 2024-12-10
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatment Ended

2024-517467-23-00 steroid sensitive idiopathic nephrotic syndrome 5 2024-11-29